173 Avsnitt

  1. Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing

    Publicerades: 2022-06-07

  2. Ep114: Chris Gibson on Industrializing Drug Discovery

    Publicerades: 2022-05-23

  3. Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs

    Publicerades: 2022-05-09

  4. Ep112: Bernat Olle on Microbiome Therapeutics

    Publicerades: 2022-04-18

  5. Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery

    Publicerades: 2022-03-14

  6. Ep110: Michele Andrasik on Making Clinical Trials More Diverse

    Publicerades: 2022-03-01

  7. Ep109: Derrell Porter on Cell Therapy Commercialization

    Publicerades: 2022-02-15

  8. Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules

    Publicerades: 2022-01-31

  9. Ep107: Bassil Dahiyat on Antibody Engineering & Company Building

    Publicerades: 2022-01-11

  10. Ep106: Vineeta Agarwala on Health Data & VC Investing

    Publicerades: 2021-12-20

  11. Ep105: Nello Mainolfi on Targeted Protein Degraders

    Publicerades: 2021-12-06

  12. Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity

    Publicerades: 2021-12-01

  13. Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer

    Publicerades: 2021-11-23

  14. Ep102: David Baltimore Reflects on a Life in Science

    Publicerades: 2021-11-08

  15. Ep101: Tony Kulesa on Fostering Founder-Led Biotechs

    Publicerades: 2021-10-26

  16. Ep100: Christian Henry on Long Read DNA Sequencing

    Publicerades: 2021-10-13

  17. Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations

    Publicerades: 2021-09-27

  18. Ep98: Mara Aspinall on Diagnostics and COVID-19

    Publicerades: 2021-09-13

  19. Ep97: John Evans on Base Edited Therapeutics

    Publicerades: 2021-09-07

  20. Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids

    Publicerades: 2021-08-09

4 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site